Estimation of dengue virus IgM persistence using regression analysis

Clinical and Vaccine Immunology

Volumn 18, Issue 12, 2011, Pages 2183-2185

  Prince, Harry E ^a   Matud, Jose L ^a  

^a Focus Diagnostics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CONTROLLED STUDY; CROSS REACTION; DENGUE; DENGUE VIRUS; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOGLOBULIN PRODUCTION; MAJOR CLINICAL STUDY; PERSISTENT VIRUS INFECTION; PREDICTIVE VALUE; PRIMARY INFECTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SECONDARY INFECTION; VIRUS DETECTION;

ANTIBODIES, VIRAL; DENGUE; DENGUE VIRUS; FOLLOW-UP STUDIES; HUMANS; IMMUNOGLOBULIN M; REGRESSION ANALYSIS; TIME FACTORS;

EID: 83455210243     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05425-11     Document Type: Article

References (18)

1. Blacksell, S. D., et al. 2008. Evaluation of the Panbio dengue virus nonstructural 1 antigen detection and immunoglobulin M antibody enzyme-linked immunosorbent assays for the diagnosis of acute dengue infections in Laos. Diagn. Microbiol. Infect. Dis. 60:43-49.
2. Gubler, D. J. 1998. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11:480-496.
3. Guzmán, M. G., and G. Kouri. 1996. Advances in dengue diagnosis. Clin. Diagn. Lab. Immunol. 3:621-627.
4. Innis, B. L., et al. 1989. An enzyme-linked immunosorbent assay to characterize dengue infections where dengue and Japanese encephalitis co-circulate. Am. J. Trop. Med. Hyg. 40:418-427.
5. Koraka, P., et al. 2001. Kinetics of dengue virus-specific immunoglobulin classes and subclasses correlate with clinical outcome of infection. J. Clin. Microbiol. 39:4332-4338.
6. Monath, T. P. 1994. Dengue: the risk to developed and developing countries. Proc. Natl. Acad. Sci. U. S. A. 91:2395-2400.
7. Morens, D. M., and A. S. Fauci. 2008. Dengue and hemorrhagic fever. A potential threat to public health in the United States. JAMA 299:214-216.
8. Nogueira, R. M. R., M. P. Miagostovich, S. M. B. Cavalcanti, K. B. F. Marzochi, and H. G. Schatzmayr. 1992. Levels of IgM antibodies against dengue virus in Rio de Janeiro, Brazil. Res. Virol. 143:423-427.
9. Prince, H. E., et al. 2005. Development and persistence of West Nile Virus immunoglobulin M (IgM), IgA, and IgG during follow-up of viremic blood donors. J. Clin. Microbiol. 43:4316-4320.
10. Prince, H. E., C. Yeh, and M. Lapé-Nixon. 2011. Utility of IgM/IgG ratio and IgG avidity for distinguishing primary and secondary dengue virus infections using sera collected more than 30 days after disease onset. Clin. Vaccine Immunol. 18:1951-1956.
11. R Development Core Team. 2009. A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. http://www.R-project.org.
12. Rothman, A. L., and F. A. Ennis. 1999. Immunopathogenesis of dengue hemorrhagic fever. Virology 257:1-6.
13. Sa-Ngasang, A., S. Anantapreecha, A. A-Neugoonpipat, et al. 2006. Specific IgM and IgG responses in primary and secondary dengue virus infections determined by enzyme-linked immunosorbent assay. Epidemiol. Infect. 134:820-825.
14. Schilling, S., D. Ludolfs, L. V. An, and H. Schmitz. 2004. Laboratory diagnosis of primary and secondary dengue infection. J. Clin. Virol. 31:179-184.
15. Solomon, T., and M. Mallewa. 2001. Dengue and other emerging flaviviruses. J. Infect. 42:104-115.
16. Vaughn, D. W., et al. 1997. Dengue in the early febrile phase: viremia and antibody responses. J. Infect. Dis. 176:322-330.
17. Vaughn, D. W., et al. 1999. Rapid serologic diagnosis of dengue virus infection using a commercial capture ELISA that distinguishes primary and secondary infections. Am. J. Trop. Med. Hyg. 60:693-698.
18. Vázquez, S., et al. 2007. Kinetics of antibodies in sera, saliva, and urine samples from adult patients with primary or secondary dengue 3 virus infections. Int. J. Infect. Dis. 11:256-262.